Post by
OneRandomGuy on May 23, 2018 3:28pm
Frost & Sullivan 2018 Technology Innovation Award
NanoSphere Health Sciences wins a prestigious award. A couple points in this really stood out for me.
"The Technology Innovation category of 2018 was awarded based on criteria including technology attributes, future business value, application diversity, customer acquisition and beyond. Previous winners of this Technology Innovation Award include key pharmaceutical players such as Nemaura Medical, Boehringer Ingelheim, 3M and Acino"
"Independent research concluded that NanoSphere Health Sciences has achieved truly superior delivery of pharmaceutical, cosmetic, and nutraceutical agents and that it outperforms competing solutions by providing significant biocompatibility, safety, efficacy and versatility. It was recognized that NanoSphere Health Sciences has effectively solved a complex problem in drug delivery with its unique ability to control the efficacy of drug formulations once inside the body."
"NanoSphere Health Sciences recently received the patent for this technology, giving it ownership over the biggest development in non-invasive medical delivery in over 25 years."
"NanoSphere Health Sciences stood out from its competitors in the 2018 Technology Innovation category. Each year, we look for disruptive technology that solves the most complex problems in the scientific world," said Marta Piotrowska, Senior Research Analyst at Frost & Sullivan, who provided the independent analysis that led to this award. "Looking ahead, the application potential for this revolutionary NanoSphere Delivery System™ is limitless, stretching from big pharma to the personal care and beauty markets. For its strong overall performance that addresses major challenges and opens opportunities within the nano-encapsulation market, NanoSphere Health is recognized with Frost & Sullivan's 2018 Technology Innovation Award."
You can read the full release at the link below
[url=Another win for NanoSphere Health Sciences and their sub products under the Evolve Formulas subsidiary. (CSE:NSHS) (OTC:NSHSF) "The Technology Innovation category of 2018 was awarded based on criteria including technology attributes, future business value, application diversity, customer acquisition and beyond. Previous winners of this Technology Innovation Award include key pharmaceutical players such as Nemaura Medical, Boehringer Ingelheim, 3M and Acino." $NSHS https://www.prnewswire.com/news-releases/nanosphere-health-sciences-wins-prestigious-frost--sullivan-2018-technology-innovation-award-300653368.html]Press Release[/url]